genOway
ALGEN.PA
#9978
Rank
S$45.17 M
Marketcap
S$3.73
Share price
-2.35%
Change (1 day)
-30.32%
Change (1 year)

P/E ratio for genOway (ALGEN.PA)

P/E ratio at the end of 2024: 21.1

According to genOway's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 13.9433. At the end of 2024 the company had a P/E ratio of 21.1.

P/E ratio history for genOway from 2009 to 2024

PE ratio at the end of each year

Year P/E ratio Change
202421.1-16.52%
202325.2-44.63%
202245.6-140.43%
2021-113286.02%
2020-29.2296%
2019-7.38-132.26%
201822.9280.82%
20176.00-70.47%
201620.3-93.18%
2015298-27.8%
20144131256.35%
201330.5-209.37%
2012-27.9-213.13%
201124.6-3.35%
201025.5-78.61%
2009119

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.